Rolih SD. High-titer, low-avidity (HTLA) antibodies and antigens: a review. Transfus Med Rev 1989;3:128–39.10.1016/S0887-7963(89)70074-2Search in Google Scholar
Issitt PD. Applied blood group serology. 4th ed. Durham, NC: Montgomery Scientific Publications, 1998.Search in Google Scholar
Issitt PD. Applied blood group serology. 2nd ed. Oxnard, CA: Spectra Biologicals, 1975.Search in Google Scholar
Sabo B, Moulds JJ, McCreary J. Anti-JMH: another high titer-low avidity antibody against a high frequency antigen (abstract). Transfusion 1978;18:387.Search in Google Scholar
Baldwin ML, Ness PM, Barrasso C, et al. In vivo studies of the long-term 51Cr red cell survival of serologically incompatible red cell units. Transfusion 1985;25:34–8.10.1046/j.1537-2995.1985.25185116499.x3969699Search in Google Scholar
Daniels GL, Green C, Lomas C, Tippet P. Monoclonal antibodies recognizing high-frequency RBC antigens, including type 2H and JMH (abstract). Transfusion 1981:21;612.Search in Google Scholar
Daniels GL, Knowles RW. A monoclonal antibody to the high frequency red cell antigen JMH. J Immunogenet 1982;9:57–9.10.1111/j.1744-313X.1982.tb00783.xSearch in Google Scholar
Moulds JJ, Levene C, Zimmernam S. Serological e vidence for heterogeneity among antibodies compatible with JMH-negative red cells (abstract). Abstracts of the Joint Meeting of the 19th Congress of the International Society of Haematology and the 17th Congress of the International Society of Blood Transfusion. 1982:287.Search in Google Scholar
Telen MJ, Rosse WF, Parker CJ, Moulds MK, Moulds JJ. Evidence that several high-frequency human blood group antigens reside on phosphatidylinositol-linked erythrocyte membrane proteins. Blood 1990;75:1404–7.10.1182/blood.V75.7.1404.1404Search in Google Scholar
Bobolis KA, Moulds JJ, Telen MJ. Isolation of the JMH antigen on novel phosphatidylinositol-linked human membrane protein. Blood 1992;79:1574–81.10.1182/blood.V79.6.1574.1574Search in Google Scholar
Mudud R, Rao N, Angelisova P, Horejsi V, Telen MJ. Evidence that CDw108 membrane protein bears the JMH blood group antigen. Transfusion 1995;35:566–70.10.1046/j.1537-2995.1995.35795357878.x7631388Search in Google Scholar
Yamada A, Kubo K, Takeshita T, et al. Molecular cloning of a glycosylphosphatidylinositol-anchored molecule CDw108. J Immunol 1999;162:4094–100.Search in Google Scholar
Daniels GL, Anstee DJ, Cartron JP, et al. International Society of Blood Transfusion Working Party on Terminology for Red Cell Surface Antigens. Vox Sang 2001;80:193–7.10.1046/j.1423-0410.2001.00024.x11449960Search in Google Scholar
Seltsam A, Strigens S, Levene C, et al. The molecular diversity of Sema7A, the semaphorin that carries the JMH blood group antigens. Transfusion 2007;47:133–46.10.1111/j.1537-2995.2007.01076.x17207242Search in Google Scholar
Richard M, St-Laurent J, Perreault J, Long A, St-Louis M. A new SEMA7A variant found in Native Americans with alloantibody. Vox Sang 2011;100:322–6.10.1111/j.1423-0410.2010.01413.x20854351Search in Google Scholar
Daniels G, Flegel WA, Fletcher A, et al. International Society of Blood Transfusion Committee on Terminology for Red Cell Surface Antigens: Cape Town report. Vox Sang 2007;92: 250–3.10.1111/j.1423-0410.2007.00887.x17348875Search in Google Scholar
Storry JR, Castilho L, Daniels G, et al. International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report. Vox Sang 2011; 101:77–82.10.1111/j.1423-0410.2010.01462.x549784821401621Search in Google Scholar
Suzuki K, Okuno T, Yamamoto M, et al. Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin. Nature 2007;446:680–4.10.1038/nature0565217377534Search in Google Scholar
Kikutani H, Kumanogh A. Semaphorins in interactions between T cells and antigen-presenting cells. Nat Rev Immunol 2003;3:159–67.10.1038/nri100312563299Search in Google Scholar
Yazdani U, Terman JR. The semaphorins. Genome Biol 2006; 7:211.10.1186/gb-2006-7-3-211155774516584533Search in Google Scholar
Holmes S, Downs AM, Fosberry A, et al. Sema7A is a potent monocyte stimulator. Scand J Immunol 2002;56:270–5.10.1046/j.1365-3083.2002.01129.x12193228Search in Google Scholar
Gras C, Eiz-Vesper B, Seltsam A, Immenschuh S, Blasczyk R, Figueiredo. Semaphorin 7A protein variants differentially regulate T-cell activity. Transfusion 2013;53:270–83.10.1111/j.1537-2995.2012.03812.x22845496Search in Google Scholar
Koh J-M, Oh B, Lee JY, et al. Association study of semaphorin 7a (sema7a) polymorphisms with bone mineral density and fracture risk in postmenopausal Korean women. J Hum Genet 2006;51:112–17.10.1007/s10038-005-0331-z16372136Search in Google Scholar
Kang H-R, Lee CG, Homer RJ, Elias JA. Semaphorin 7A plays a critical role in TGF-beta1-induced pulmonary fibrosis. J Exp Med 2007;204:1083–93.10.1084/jem.20061273211857517485510Search in Google Scholar
Anstee DJ. The functional importance of blood group-active molecules in human red blood cells. Vox Sang 2011;100:140–9.10.1111/j.1423-0410.2010.01388.x21175664Search in Google Scholar
Bartholdson SJ, Bustamente LY, Crosnier C, et al. Semaphorin-7A is an erythrocyte receptor for P. falciparum merozoite-specific TRAP homolog, MTRAP. PLoS Pathog 2012; 8:e1003031.10.1371/journal.ppat.1003031349958323166499Search in Google Scholar
Kollmar M, South SF, Tregellas WM. Evidence of a genetic mechanism for the production of the JMH negative phenotype (abstract). Transfusion 1981;21:612.Search in Google Scholar
Daniels G. Human blood groups. 3rd ed. Wiley-Blackwell, 2013:467.10.1002/9781118493595Search in Google Scholar
Stroka-Lee AH, Halverson GR. Collecting GPI-negative RBCs from patients with paroxysmal nocturnal hemoglobinuria for use in serological investigations (abstract). Transfusion 2010;50(Suppl):167A.Search in Google Scholar
Whitsett CF, Moulds M, Pierce JA, Hare V. Anti-JMH identified in serum and eluate from red cells of a JMH-negative man. Transfusion 1983;23:344–5.10.1046/j.1537-2995.1983.23483276874.x6410552Search in Google Scholar
Tregellas WM, Pierce SR, Harding JT, Beck ML. Anti-JMH: IgG subclass composition and clinical significance (abstract). Transfusion 1980;20:628.Search in Google Scholar
Garratty G, Arndt P, Nance S. IgG subclass of blood group alloantibodies to high frequency antigens (abstract). Transfusion 1996;36(Suppl 9S):50S.Search in Google Scholar
Pope J, Lubenko A, Lai WYY. A survey of the IgG subclasses of antibodies to high frequency red cell antigens (abstract). Transf Med 1991;1(Suppl 2):58.Search in Google Scholar
Geisland J, Corgan M, Hillard B. An example of anti-JMH with characteristics of a clinically significant antibody. Immunohematology 1990;6:9–11.10.21307/immunohematology-2019-1031Search in Google Scholar
Seltsam A, Agaylan A, Grueger D, Meyer O, Blasczyk R, Salama A. Rapid detection of JMH antibodies with recombinant Sema7A (CD108) protein and the particle gel immunoassay. Transfusion 2008;48:1151–5.10.1111/j.1537-2995.2008.01660.x18422858Search in Google Scholar
Baldwin ML, Ness PM, Barrasso C, et al. In vivo studies of the long-term 51Cr red cell survival of serologically incompatible red cell units. Transfusion 1985;25:34–8.10.1046/j.1537-2995.1985.25185116499.x3969699Search in Google Scholar
Mudad R, Rao N, Issitt PD, Roy RB, Combs MR, Telen MJ. JMH variants: serologic, clinical, and biochemical analyses in two cases. Transfusion 1995;35:925–30.10.1046/j.1537-2995.1995.351196110897.x8604490Search in Google Scholar
Hoppe B, Pastucha L, Seltsam A, Greinacher A, Salama A. Acute haemolytic transfusion reactions due to weak antibodies that in vitro did not seem to be clinically significant. Vox Sang 2002;82:207–10.10.1046/j.1423-0410.2002.00171.x12047515Search in Google Scholar
